[Juvenile idiopathic arthritis-Diagnosis and management]

Area of Science:

• Pediatric Rheumatology
• Clinical Immunology

Background:

• Juvenile idiopathic arthritis (JIA) is the most prevalent chronic rheumatic condition affecting children and adolescents.
• Diagnosis can be challenging, especially in very young children, requiring exclusion of age-specific conditions.
• Current classification relies on the International League of Associations for Rheumatology (ILAR) criteria into seven categories.

Purpose of the Study:

• To highlight the importance of early and effective treatment strategies for JIA.
• To emphasize the need for category-specific and comorbidity-informed treatment approaches.
• To stress the necessity of a structured transition from pediatric to adult rheumatology care.

Main Methods:

• Diagnosis is primarily clinical, involving differential diagnosis.
• Treatment strategies are guided by JIA category, comorbidities, and consensus treatment plans (e.g., German ProKind initiative).
• A treat-to-target approach is recommended.

Main Results:

• Early and effective treatment is crucial for minimizing disease burden, chronic morbidity, and improving quality of life.
• Treatment plans should align with established guidelines and strategies.
• A significant proportion of JIA patients experience persistent symptoms into adulthood.

Conclusions:

• Timely and appropriate management of JIA is essential for optimal patient outcomes.
• Adherence to consensus treatment plans and a treat-to-target strategy are key.
• A seamless transition of care from pediatric to adult services is critical for long-term health management in JIA patients.